Literature DB >> 32551282

Role of Endoscopic Internal Maxillary Artery Ligation in Intractable Idiopathic Epistaxis.

Vivek Sasindran1, Mithra Sara John1.   

Abstract

The protocols for managing intractable idiopathic epistaxis have evolved with advances in endoscopic techniques. Transnasal endoscopic sphenopalatine artery ligation (TESPAL) has been the treatment of choice for idiopathic intractable epistaxis. If TESPAL fails, transantral ligation of internal maxillary artery (IMA) used to be the dictum along with radiological interventions. Here we discuss about the role of endoscopic IMA ligation in cases of failed TESPALs. Retrospective study at a tertiary hospital was performed. 28 cases of intractable idiopathic epistaxis underwent TESPAL in our institution of which 2 cases had rebleed. We also had two referred cases of failed TESPALS. Of this 4 patients, three patients underwent endoscopic IMA ligation and one patient underwent selective embolisation. All the patients who underwent endoscopic IMA ligation for failed TESPAL had no further episodes of epistaxis. One patient who underwent selective embolization also had no further episodes of bleed but had transient facial pain and trismus. When TESPAL fails, endoscopic IMA ligation can be considered as an alternative procedure before resorting to embolization. © Association of Otolaryngologists of India 2020.

Entities:  

Keywords:  Endoscopic internal maxillary artery (IMA) ligation; Intractable idiopathic epistaxis; Transnasal endoscopic sphenopalatine artery ligation (TESPAL)

Year:  2020        PMID: 32551282      PMCID: PMC7276470          DOI: 10.1007/s12070-020-01788-y

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  18 in total

1.  Endoscopic endonasal ligation of the sphenopalatine artery.

Authors:  B Ram; P S White; H A Saleh; T Odutoye; A Cain
Journal:  Rhinology       Date:  2000-09       Impact factor: 3.681

2.  TRANSANTRAL LIGATION OF THE INTERNAL MAXILLARY ARTERY FOR EPISTAXIS.

Authors:  J R CHANDLER; A J SERRINS
Journal:  Laryngoscope       Date:  1965-07       Impact factor: 3.325

3.  Anatomical variability of the maxillary artery: findings from 100 Asian cadaveric dissections.

Authors:  Jin Kook Kim; Jae Hoon Cho; Yeo-Jin Lee; Chang-Hoon Kim; Jung Ho Bae; Jeung-Gweon Lee; Joo-Heon Yoon
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-08

4.  Endoscopic ligation of the internal maxillary artery for treatment of intractable posterior epistaxis.

Authors:  J B Pritikin; D D Caldarelli; W R Panje
Journal:  Ann Otol Rhinol Laryngol       Date:  1998-02       Impact factor: 1.547

5.  Unilateral vs bilateral sphenopalatine artery ligation in adult unilateral epistaxis: A comparative retrospective study of 83 cases.

Authors:  Rémi Hervochon; Nadim Khoueir; Nicolas Le Clerc; Jourdaine Clément; Romain Kania; Philippe Herman; Benjamin Verillaud
Journal:  Clin Otolaryngol       Date:  2018-07-25       Impact factor: 2.597

6.  Therapeutic percutaneous embolization in intractable epistaxis.

Authors:  J Sokoloff; I Wickbom; D McDonald; F Brahme; T C Goergen; L E Goldberger
Journal:  Radiology       Date:  1974-05       Impact factor: 11.105

7.  Transantral sphenopalatine artery ligation.

Authors:  G T Simpson; P Janfaza; G D Becker
Journal:  Laryngoscope       Date:  1982-09       Impact factor: 3.325

8.  Septal perforation and bilateral partial middle turbinate necrosis after bilateral sphenopalatine artery ligation.

Authors:  E Elsheikh; M W El-Anwar
Journal:  J Laryngol Otol       Date:  2013-09-04       Impact factor: 1.469

9.  Etiological profile and treatment outcome of epistaxis at a tertiary care hospital in Northwestern Tanzania: a prospective review of 104 cases.

Authors:  Phillipo L Chalya; Japhet M Gilyoma
Journal:  BMC Ear Nose Throat Disord       Date:  2011-09-05

10.  Bilateral facial nerve paralysis following arterial embolization for epistaxis.

Authors:  R Metson; D G Hanson
Journal:  Otolaryngol Head Neck Surg       Date:  1983-06       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.